Screener
Xeris Biopharma Holdings, Inc. XERS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 61,035 | 44,393 | 114,179 | 88,411 |
| Amortization of intangible assets | 2,711 | 2,711 | 5,421 | 5,421 |
| Total costs and expenses | 86,927 | 67,057 | 162,138 | 130,266 |
| Income from operations | 5,173 | 4,482 | 13,089 | 1,392 |
| Other income (expense): | ||||
| Interest and other income | 1,455 | 948 | 2,657 | 2,123 |
| Loss on debt extinguishment, net | (30,782) | — | (30,782) | — |
| Interest expense | (6,947) | (7,358) | (13,831) | (14,663) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s operating income?
- Xeris Biopharma Holdings, Inc. (XERS) reported operating income of $5.17M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s operating income changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s operating income increased by 15.4% year-over-year, from $4.48M to $5.17M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s operating income?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s operating income has grown at a -31.8% compound annual growth rate (CAGR), from -$115.16M to $24.9M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Xeris Biopharma Holdings, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude